MLA Diagnostics develops an in vitro diagnostic (IVD) method to determine melanoma patients' metastatic risk. Their test aims to provide more accurate prognostic information for melanoma patients after diagnosis.

MLA Diagnostics

Viewport Meta

IPhone / Mobile Compatible

Google Font API

Google Maps

WordPress

nginx

Microsoft Exchange Online

DMARC

Office 365 Mail

Egbert Smit

Manon van Engeland

Inventor

European Union (EU) Health Care Companies (Top 10K)

The Netherlands Companies With Fewer Than 10 Employees (Top 10K)

Europe Health Care Companies (Top 10K)

Europe, Middle East, and Africa (EMEA) Medical Companies (Top 10K)

MLA Diagnostics is developing the Ly75 indicator, a prognostic biomarker that can effectively predict patients’ clinical outcomes. Moreover, the marker is inexpensive, robust, and efficient. Based on the outcome of the MLA Diagnostics biomarker test, patients and physicians can together choose a more effective and personalised treatment path.

Venture Round - MLA Diagnostics

Pre Seed Round - MLA Diagnostics

Maastricht

Limburg

The Netherlands

Europe

Dutch-based MLA Diagnostics raises funds for clinical trials in tailored skin cancer treatments

A diagnostic test that uses methylation-specific PCR to determine the metastatic risk of melanoma patients by analyzing the methylation status of the LY75 gene promoter.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Aug 9, 2024 10:15 PM	dd518aec
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 22, 2024 7:44 AM	cb8e1f84
crunchbase profile	general	Nov 22, 2024 10:11 AM	28d1bf5c
li profile	general
translate crunchbase fundingrounds	general	Nov 22, 2024 2:18 PM	4bb1dcb4
peers	general	Aug 9, 2024 10:15 PM	bd97e700
news basic	general	Aug 9, 2024 10:15 PM	d5ff8f7c
bundesanzeiger	filings
financials download nd	financials
private financials	financials

MLAD

COM:MLADX

MLA Diagnostics